Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Rx Industry CEOs Are Taking “Positive” Steps On GMPs, FDA’s Galson Says

Executive Summary

FDA's discussions with pharmaceutical industry CEOs over the past year give the agency confidence that manufacturing quality is improving, Center for Drug Evaluation & Research Deputy Director Steven Galson, MD, told the Schwab Washington Research Group conference May 2
Advertisement

Related Content

Schering NDAs Are Clear For Review Under FDA Consent Decree
Schering NDAs Are Clear For Review Under FDA Consent Decree
FDA PAT Inspection Teams Being Formed: Further Training Set For Fall
FDA PAT Inspection Teams Being Formed: Further Training Set For Fall
PDUFA III Critics Face Uphill Fight To Keep Bill Out Of Bioterrorism Package
Advertisement
UsernamePublicRestriction

Register

PS039795

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel